Cargando…
Decentralized, Community-Based Hepatitis C Point-of-Care Testing and Direct-Acting Antiviral Treatment for People Who Inject Drugs and the General Population in Myanmar: Protocol for a Feasibility Study
BACKGROUND: The advent of direct-acting antivirals (DAAs) and point-of-care (POC) testing platforms for hepatitis C allow for the decentralization of care to primary care settings. In many countries, access to DAAs is generally limited to tertiary hospitals, with limited published research documenti...
Autores principales: | Draper, Bridget Louise, Pedrana, Alisa, Howell, Jessica, Yee, Win Lei, Htay, Hla, Aung, Khin Sanda, Shilton, Sonjelle, Kyi, Khin Pyone, Naing, Win, Hellard, Margaret |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388045/ https://www.ncbi.nlm.nih.gov/pubmed/32673260 http://dx.doi.org/10.2196/16863 |
Ejemplares similares
-
Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up
por: Draper, Bridget Louise, et al.
Publicado: (2022) -
Outcomes of the CT2 study: A ‘one‐stop‐shop’ for community‐based hepatitis C testing and treatment in Yangon, Myanmar
por: Draper, Bridget Louise, et al.
Publicado: (2021) -
Cost‐effectiveness of a decentralized, community‐based “one‐stop‐shop” hepatitis C testing and treatment program in Yangon, Myanmar
por: Win, Thin Mar, et al.
Publicado: (2023) -
Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits
por: Scott, Nick, et al.
Publicado: (2021) -
Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients
por: Draper, Bridget, et al.
Publicado: (2022)